| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/22/2006 | DE102004060997A1 New tetrahydroquinoline compounds are cholesterol ester transfer protein inhibitors useful for primary and/or secondary prevention of coronary heart disease; and for treatment and/or prevention of e.g. hypolipoproteinemia and dyslipidemia |
| 06/22/2006 | DE102004060752A1 New heteroaryloxy-substituted phenylamino pyrimidine compounds are Rho-kinase inhibitors useful for the treatment and/or prophylaxis of cardiovascular diseases e.g. myocardial infarction and arrhythmia, erectile dysfunction and cancers |
| 06/22/2006 | CA2604463A1 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents |
| 06/22/2006 | CA2590881A1 Silicon compounds and their use |
| 06/22/2006 | CA2590877A1 Silicon compounds and their use |
| 06/22/2006 | CA2590845A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | CA2590843A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | CA2590778A1 Il-15 antigen arrays and uses thereof |
| 06/22/2006 | CA2590391A1 Use of ppar agonists for the treatment of congestive heart failure |
| 06/22/2006 | CA2590294A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/22/2006 | CA2590278A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and hmg coa reductase inhibitors |
| 06/22/2006 | CA2589493A1 Combination therapy comprising telmisartan and hydrochlorothiazide |
| 06/21/2006 | EP1671973A2 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP1671965A2 Oxacarbocyclic oligomers of fumaric acid |
| 06/21/2006 | EP1671961A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1671949A2 Substituted phenylamines and pyridinylamines |
| 06/21/2006 | EP1671948A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1671650A1 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
| 06/21/2006 | EP1671633A1 Use of PPAR agonists for the treatment of congestive heart failure |
| 06/21/2006 | EP1671632A1 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors |
| 06/21/2006 | EP1671129A1 Compounds and methods for promoting angiogenesis by using a gamma-secretase inhibitor or inhibiting the gamma-secretase pathway |
| 06/21/2006 | EP1670814A1 Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-n-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compounds |
| 06/21/2006 | EP1670749A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
| 06/21/2006 | EP1670551A1 Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias |
| 06/21/2006 | EP1670491A2 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 06/21/2006 | EP1670484A1 Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
| 06/21/2006 | EP1670470A1 Pyridine derivatives and use thereof as urotensin ii antagonists |
| 06/21/2006 | EP1670466A2 Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors |
| 06/21/2006 | EP1670461A1 Oral pharmaceutical formulations containing the active ingredient irbesartan |
| 06/21/2006 | EP1670459A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 06/21/2006 | EP1670449A2 Thyroid hormone analogs and methods of use in angiogenesis |
| 06/21/2006 | EP1670445A2 Methods of preventing or treating recurrence of myocardial infarction |
| 06/21/2006 | EP1670418A2 Chitosan spinning method, device therefor, and resulting chitosan yarn, and uses thereof |
| 06/21/2006 | EP1506193B1 Carbamate-substituted pyrazolopyridines |
| 06/21/2006 | EP1450797B1 Benzothiazole derivatives |
| 06/21/2006 | EP1438316B1 Phosphonic acid compounds as inhibitors of serine proteases |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1309322B1 Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders |
| 06/21/2006 | EP1305020B1 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 06/21/2006 | EP1303306B1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 06/21/2006 | EP1276476B1 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations |
| 06/21/2006 | EP1268419B1 Pyrrolidine derivatives useful as bax inhibitors |
| 06/21/2006 | EP1244647B1 Quinazoline derivatives as vegf inhibitors |
| 06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 06/21/2006 | EP1146872B1 Use of angiotensin ii receptor antagonists for treating acute myocardial infarction |
| 06/21/2006 | EP1025106B1 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP0971601B1 Decaffeinated mate extracts and the use thereof |
| 06/21/2006 | CN1791594A 2-aminoquinoline derivative |
| 06/21/2006 | CN1791429A Composition comprising a PDE4 inhibitor and a PDE5 inhibitor |
| 06/21/2006 | CN1791425A C1 inhibitor with short half-life for transient treatment |
| 06/21/2006 | CN1791422A Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 06/21/2006 | CN1791414A Use of steroid derivatives for the treatment of angiotensin ii related disease e.g. cardiovascular and proliferative disorders |
| 06/21/2006 | CN1791411A Activation specific inhibitors of NF-kB and method of treating inflammatory processes in cardio-vascular diseases |
| 06/21/2006 | CN1791394A Preventive and/or therapeutic agent for inflammatory bowel disease |
| 06/21/2006 | CN1789244A Pyrrolidine derivative, preparation method thereof and pharmaceutical composition containing the compound |
| 06/21/2006 | CN1788791A Papain-containing capsule for regulating blood fat and reducing blood pressure |
| 06/21/2006 | CN1788785A Pharmaceutical composition for treating and preventing thrombus and its preparation method |
| 06/21/2006 | CN1788769A Sumatra dragonsblood soft capsule and its preparation method |
| 06/21/2006 | CN1788753A General glycoside extract from tree peony root bark and its preparation method and uses thereof |
| 06/21/2006 | CN1788750A Chinese medicinal preparation for treating qi obstruction in chest and chest pain and its preparation process |
| 06/21/2006 | CN1788749A Preparation method of capsule containing red sage root and notoginseng |
| 06/21/2006 | CN1788748A Injection formulation containing raw material herb red sage root and its quality control method |
| 06/21/2006 | CN1788731A Compound injection preparation containing ligustrazine and breviscapine and its preparation method |
| 06/21/2006 | CN1788622A Health drink possessing liver harmonization and qi dredging function |
| 06/21/2006 | CN1788609A Preparation method of gastrodia tuber essence serial health product |
| 06/21/2006 | CN1260336C Vegetable fat Europe plum oil and its method of extraction and application |
| 06/21/2006 | CN1260245C Diosgenin butanedioic acid monoester derivative and its preparation method and application |
| 06/21/2006 | CN1260244C Diosgenin amino ester derivative and its preparation method and application |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260226C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 06/21/2006 | CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives |
| 06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
| 06/21/2006 | CN1260215C Antagon of endostadin receptor pyrazole carboxylic acids |
| 06/21/2006 | CN1259972C Anticoagulant agent and humanized anti-von willebrand factor monoclonal antibody |
| 06/21/2006 | CN1259956C Chinese medicine composition for treating heart, kidney and multiple-organ failure and its preparation |
| 06/21/2006 | CN1259934C Haw leaf injection for treating cardiovascular disease |
| 06/21/2006 | CN1259933C Chinese medicinal composition for treating coronary disease and its preparation and application |
| 06/21/2006 | CN1259925C Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 06/21/2006 | CN1259920C Biologically active agents and drugs |
| 06/21/2006 | CN1259918C Use of bile acid or bile salt fatty acid conjugates |
| 06/21/2006 | CN1259915C Effective-component extract of Foliun-Mori and its preparation method |
| 06/21/2006 | CN1259914C Use of scopoletin in preparing medicine for preventing and curing hyperuricemia |
| 06/21/2006 | CN1259912C Citalopram for the treatment of elevated blood pressure |
| 06/21/2006 | CN1259908C Hydrolysis-optimized liplid emulsions and use thereof |
| 06/21/2006 | CN1259903C Slow release bioadhesive buccal tablet |
| 06/21/2006 | CN1259851C Extractive product of sunflower |
| 06/20/2006 | US7064229 Succinic acid derivatives |
| 06/20/2006 | US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents |
| 06/20/2006 | US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 06/20/2006 | US7064204 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders |
| 06/20/2006 | US7064200 Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064147 Amino acids with affinity for the α-2-delta-protein |
| 06/20/2006 | US7064141 Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy |
| 06/20/2006 | US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/20/2006 | US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 06/20/2006 | US7064134 4-piperidinyl-substituted, e.g., 4-(2-methyl-4-piperidin-1-yl-quinolin-7-ylmethoxy)-benzonitrile; treating eating disorders and obesity |
| 06/20/2006 | US7064128 Preferentially substituted calcium channel blockers |